ESMO Virtual Review Featuring Massive Bio

The 2021 ESMO Virtual Review featuring Massive Bio was hosted on Saturday October 23^rd until the 24^th by Total Health Conferencing. The 2021 Virtual ESMO (European Society For Medical Oncology) Review gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This meeting facilitated the discussion of translational cancer science in a virtual format. Attendees of the event received 9.50 CME/CE credits + MOC points.

Massive Bio Co-founders Selin Kurnaz and Dr. Arturo Loaiza-Bonilla, MD were featured in “Innovative Strategies for Clinical Trial Enrollment”. Watch the full video to hear more about how digital tools are increasing clinical trial participation such as Massive Bio’s Artificial Intelligence (AI) based clinical trial matching. Fill out the form to watch the full conference. Topics covered during the live session included:

• Worldwide cancer statistics
• Precision of oncology
• Relation between comprehensive profile and clinical trials
• Demand and supply in Oncology
• Underrepresentation in clinical trials
• The current clinical trial enrollment value chain
• Digital health tools that try to show impact on clinical trials
• Massive Bio vision and mission

To learn more about the ESMO Virtual Review, visit Total Health Conferencing. Total Health Conferencing is a medical information company made up of planning experts who produce tailored content, courses, and conferences for oncology healthcare providers, whether virtual or in-person. Use #ESMO21 to stay up to date with ESMO 2021 and tag @MassiveBio to share which conferences you attended! You can find a record of it on our YouTube Channel or you can submit a form on this page and watch a recording of the session directly.